Moderna Spikevax TM Bivalent Vaccine (BA.1/BA.4-5) Instructions for Use

Instructions for the Moderna Spikevax TM bivalent vaccine (BA.1/BA.4-5), covering efficacy, administration, contraindications, and adverse reactions for…


Moderna Spikevax TM Bivalent Vaccine (BA.1/BA.4-5) Instructions for Use - cover page
Brand
Moderna
Document type
User Manual
Language
Chinese
Pages
2
File format
PDF
File size
438 KB
Published
17 October, 2026
Updated
17 October, 2026
MD5 checksum
B7D9D5195607D58C73EC1B790E85130E

About this manual

This document provides instructions for the Moderna Spikevax TM bivalent vaccine, which targets the original strain and Omicron variants BA.1 or BA.4-5. It is intended for booster doses starting in spring 2023 for individuals aged 12 and older who have completed their initial vaccination series. The vaccine is administered via intramuscular injection and is covered by public funding in Japan. This manual is written in Chinese.

What's inside

  • Vaccine Efficacy
  • Immunization Schedule
  • Target Population
  • Contraindications
  • Precautions
  • Adverse Reactions
  • Compensation System
  • Vaccine Composition

Specifications

Vaccine TypemRNA vaccine
Dose Volume0.5mL
Minimum Interval3 months
Active IngredientsElasomeran, Imelasomeran or Davesomeran

Frequently asked questions

Who is eligible for this booster vaccine?

Eligible groups include those aged 65 and older, individuals aged 12-64 with underlying conditions, and healthcare workers.

Can this vaccine be used for the first dose?

No, this vaccine cannot be used for the initial vaccination.

What are the main adverse reactions?

Main reactions include pain at the injection site, headache, joint and muscle pain, fatigue, chills, and fever.

How long should one wait after vaccination?

Wait at least 15 minutes; wait 30 minutes if there is a history of severe allergic reactions.

Download PDF (438 KB)